Serum β2-Microglobulin Is Closely Associated With the Recurrence Risk and 3-Month Outcome of Acute Ischemic Stroke

Conclusions: In conclusion, we inferred that serum β2M was positively associated with the recurrence risk and 3-month outcome of AIS, but it did not appear to be directly related to the severity of AIS or the size of the infarct at admission.

https://www.frontiersin.org/articles/10.3389/fneur.2019.01334

Source: Frontiers in Neurology - January 8, 2020 Category: Neurology Source Type: research